PM360 2021 Innovative Startup Unqork

Unqork

Kara Dennis, Head of Healthcare
kara.dennis@unqork.com

Global enterprises spend over half a trillion dollars annually on in-house development of software, yet these efforts frequently lead to critical issues: extensive timelines (months or years to build new software), business requirements not translated effectively into code, security risks, and other quality issues. Unqork has emerged to address this area of inefficiency in enterprise technology. Its completely visual, no-code application platform helps large enterprises build complex custom software faster, with higher quality and lower costs than traditional approaches—all without a single line of code.

While Unqork was already built for highly regulated industries such as financial services, insurance, and the public sector, the company recently ventured into the healthcare space. This presents a huge opportunity for healthcare companies to build complex, secure software without using code, and in turn, modernize the experience for every stakeholder, improve patient outcomes, and deliver cost savings for the entire system.

For example, payers can use the platform to build new member onboarding, prior authorization, and case management solutions; providers can create patient-facing digital portals and clinical decision support solutions; and life sciences companies can digitize the clinical trial set-up and monitoring process and modernize their patient services.

In 2020, just three-years after its founding, Unqork reached a $2B valuation. This growth is only expected to continue across the enterprise—by 2024, low-code/no-code application development will be responsible for more than 65% of application development activity, according to Gartner. As the healthcare industry looks to build upon the lessons of COVID-19, meet the digital expectations of its stakeholders, and address decades of technical debt, companies that adopt no-code will be able to accelerate their digital transformations and maintain a competitive advantage.

Ads

You May Also Like

PM360 2022 Innovative Company Confideo Labs

Confideo Labs Contact Person: Mike Marett, Founder mm@confideolabs.com Confideo Labs is the leading provider ...

AllazoHealth logo representing its Technology for Rare Disease Support Programs

PM360 2023 Innovative Artificial Intelligence AllazoHealth’s Technology for Rare Disease Support Programs

AllazoHealth’s Technology for Rare Disease Support Programs More Personalized Patient Support The pharmaceutical industry ...

PM360 2020 Innovative Company Mission Bio

Mission Bio Hannah Viernes, Mission Bio viernes@missionbio.com Only 3% of cancer drugs tested in ...